Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Sara Lonardi, Monica Ronzoni, Bruno Massidda, Vittorina Zagonel, Nicoletta Pella, Claudia Mucciarini, Roberto Labianca, Maria Teresa Ionta, Irene Bagaloni, Enzo Veltri, Pietro Sozzi, Sandro Barni, Vincenzo Ricci, Luisa Foltran, Mario NicoliniEdoardo Biondi, Annalisa Bramati, Daniele Turci, Silvia Lazzarelli, Claudio Verusio, Francesca Bergamo, Alberto Sobrero, Luciano Frontini, Mauro Magnani

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences